Title

ONECUT2 is a novel target for treatment of castration-resistant prostate cancer.

Document Type

Editorial

Publication Date

2-3-2020

Journal

Expert Opinion on Therapeutic Targets

Inclusive Pages

1-2

DOI

10.1080/14728222.2020.1723080

Comments

Epub ahead of print

Peer Reviewed

1

Find in your library

Share

COinS